Genus’ (GNS) Buy Rating Reaffirmed at Shore Capital

Genus (LON:GNS)‘s stock had its “buy” rating restated by Shore Capital in a research report issued on Wednesday,Digital Look reports.

Genus Stock Performance

Shares of LON GNS opened at GBX 1,660 ($21.21) on Wednesday. The company has a market cap of £1.09 billion, a P/E ratio of 13,833.33, a P/E/G ratio of 2.87 and a beta of 0.37. Genus has a 52-week low of GBX 1,478 ($18.88) and a 52-week high of GBX 2,378 ($30.38). The company has a debt-to-equity ratio of 53.54, a quick ratio of 1.08 and a current ratio of 1.80. The firm’s fifty day moving average is GBX 1,907.74 and its two-hundred day moving average is GBX 1,822.87.

Insider Buying and Selling

In other Genus news, insider Jorgen Kokke sold 2,186 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of GBX 1,956 ($24.99), for a total transaction of £42,758.16 ($54,629.05). 0.75% of the stock is owned by company insiders.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.